FDA expands approval of breast cancer drug Kisqali
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
Novartis: Kisqali Reduces Recurrence Risk By 28.5% In Late-stage Early Breast Cancer Trial
Novartis Pharma AG, affiliated to Swiss drug major Novartis AG (NVS), announced Monday updated analysis from the pivotal Phase III
Novartis Breast Cancer Drug Found To Cut Disease Recurrence
Novartis said its Kisqali breast cancer drug produced longer success for those with certain forms of the disease.
Major New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients: Weighing The Risks & Benefits of Kisqali
The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) as treatment for people with HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence.
Novartis' Kisqali Lowers Risk of Breast Cancer Recurrence by 28%
Novartis NVS announced positive data on breast cancer drug Kisqali (ribociclib) from the late-stage study, NATALEE. This late-breaking data from this four-year post-hoc analysis was presented at the European Society for Medical Oncology (“ESMO”) Congress 2024.
Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction
Kisqali is a selective cyclin-dependent kinase inhibitor that targets proteins involved in the rapid division of cancer cells.
Dearborn's Dakota Joshua diagnosed with testicular cancer
Philadelphia breast cancer survivors train for historic rowing competition in Boston
A group of Philadelphia breast cancer survivors are getting ready for a big rowing competition, the first of its kind. These ...
'Don't ignore symptoms' woman with womb cancer urges
Mrs Hentsch, 36 at the time of her diagnosis, urged other people not to ignore any unusual symptoms or changes to their ...
I’m 54 and have terminal cancer. I have a wife, 47, and an 8-year-old child. How do I split my $1.5 million estate between them?
I’m going to be 54 this month. Unfortunately, I have terminal cancer and I don’t expect to make it to 55, let alone 56 or ...
Deep Links Between Alcohol and Cancer Are Described in New Report
Increased alcohol intake in mid- to late-adulthood also worsens the risk. Alcohol has adverse effects on the microbiome, the ...
More Cancer Cases in Areas Where Incarceration Rates Are High: Study
Compared to counties that ranked in the lowest quartile of incarcerations, those in the highest fourth had a cancer death ...
Cancer deaths in U.S. fell by 33% in 30 years, but alcohol remains a lesser-known risk factor
The latest Cancer Progress Report from the American Association for Cancer Research also found a 24% decline in the overall ...
These Four Common Infections Can Cause Cancer
A new report says that 13 percent of cancers are linked to bacteria or viruses. Vaccines and treatments offer powerful ...
Report: Cancer deaths have dropped, but alcohol is major factor in new cases
Scientific advances helped avert 4.1 million deaths from cancer in the 30 years between 1991 and 2021 according to a new ...
How Listeners Detected Radio Host's Throat Cancer
When Jamie Theakston's voice began sounding off on the airwaves, his listeners didn't just tune in — they spoke up. Their ...
Why Some Men Keep Their Prostate Cancer a Secret
Disclosing a prostate cancer diagnosis can make some men vulnerable, but it has the potential to open up outlets for support.
Davis professor loses breast cancer battle months after community rallied to help find innovative therapies
Danielle Heard Mollel first shared her journey with stage 4 breast cancer with CBS13 in April. The Davis professor and mother ...